Petros Pharmaceuticals (PTPI) Stock Chart & Stock Price History $0.03 0.00 (-2.73%) As of 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Petros Pharmaceuticals Stock Price Performance The Petros Pharmaceuticals (PTPI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.75%, with a year-to-date return of -99.71%. In the past month, the stock has decreased 5.00%, reflecting recent market activity. As of the latest close, Petros Pharmaceuticals traded at $0.03 with a market cap of $913 thousand and volume of 120,575 shares. Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-18.34%1 Month Performance-5.00%3 Month Performance-97.61%Year-To-Date Performance-99.71%1 Year Performance-99.75% PTPI Stock Chart for Friday, July, 11, 2025 PTPI Chart by TradingView Petros Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/10/2025$0.03$0.03+4.64%$0.03$0.03120,575 shs$913,000.0007/09/2025$0.03$0.03-6.67%$0.03$0.03743,170 shs$872,000.0007/08/2025$0.03$0.03-5.66%$0.03$0.03763,008 shs$935,000.0007/07/2025$0.03$0.03-8.88%$0.04$0.03593,505 shs$991,000.0007/04/2025$0.03$0.03$0.04$0.03245,089 shs$1.09 million07/03/2025$0.03$0.03+0.29%$0.04$0.03245,089 shs$1.09 million07/02/2025$0.03$0.03+6.42%$0.04$0.03491,731 shs$1.08 million07/01/2025$0.03$0.03-2.39%$0.04$0.03266,638 shs$1.02 million06/30/2025$0.04$0.03-5.37%$0.04$0.03265,202 shs$1.04 million06/27/2025$0.03$0.04+5.99%$0.04$0.03605,999 shs$1.10 million Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/26/2025$0.03$0.03+4.37%$0.03$0.03349,548 shs$1.04 million06/25/2025$0.03$0.03+6.67%$0.03$0.03328,165 shs$997,000.0006/24/2025$0.03$0.03-0.33%$0.03$0.03624,658 shs$935,000.0006/23/2025$0.03$0.03+5.99%$0.03$0.03997,598 shs$938,000.0006/20/2025$0.03$0.03+5.19%$0.03$0.03274,634 shs$885,000.0006/19/2025$0.03$0.03$0.03$0.03478,145 shs$841,000.0006/18/2025$0.03$0.03-10.00%$0.03$0.03478,145 shs$841,000.0006/17/2025$0.03$0.03+11.11%$0.03$0.03303,359 shs$935,000.0006/16/2025$0.03$0.03-12.90%$0.03$0.021.30 million shs$841,000.0006/13/2025$0.03$0.03-8.01%$0.03$0.03342,831 shs$966,000.0006/12/2025$0.03$0.03+12.33%$0.03$0.03431,374 shs$1.05 million06/11/2025$0.03$0.03+9.09%$0.03$0.03835,783 shs$935,000.0006/10/2025$0.03$0.03-13.52%$0.03$0.031.30 million shs$857,000.00 Related Companies InMed Pharmaceuticals Stock Chart Titan Pharmaceuticals Stock Chart Polyrizon Stock Chart Evoke Pharma Stock Chart Lipella Pharmaceuticals Stock Chart Dermata Therapeutics Stock Chart VivoSim Labs Stock Chart Clearmind Medicine Stock Chart Can-Fite BioPharma Stock Chart Artelo Biosciences Stock Chart Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTPI) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.